INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 459m ago
HOUSE PTR59m ago
SEC 13F59m ago
ROBINHOOD CHAIN59m ago
Public company

ODTXOdyssey Therapeutics, Inc.

CIK 0001882782

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells1 / 0
Max Insider Score53
Connections4with evidence

ODTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Other acquisition or disposition
J$42K
2,351 sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Tpg Gp A, LlcFormer 10% Owner · May 13, 2026
  • ← Insider ofevidence
    Coulter James GFormer 10% Owner · May 13, 2026
  • ← Insider ofevidence
    Winkelried JonFormer 10% Owner · May 13, 2026
53
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Open-market purchase
BUY
$25.00M
1.39M sh
May 11, 2026
May 13, 2026
traded May 11, 2026
+2d
SEC FORM 4

Evidence

12
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Other acquisition or disposition
J—
423.1K sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

21
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Derivative conversion
C—
1.88M sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

12
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Other acquisition or disposition
J—
423.1K sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

9
TA
Tpg Gp A, LlcFormer 10% Owner
ODTXOdyssey Therapeutics, Inc.
Derivative conversion
C—
18.27M sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence